Your browser doesn't support javascript.
loading
Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID-19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cell.
Perram, Jacinta; Purtill, Duncan; Bajel, Ashish; Butler, Jason; O'Brien, Tracey; Teh, Benjamin; Gilroy, Nicole; Ho, Phoebe J; Doocey, Richard; Hills, Thomas; Perera, Travis; Douglas, Genevieve; Ramachandran, Shanti; Chee, Lynette; Trotman, Judith; Weinkove, Robert; Keogh, Steven; Fraser, Chris; Cochrane, Tara; Watson, Anne-Marie; Diamond, Peter; Latimer, Maya; Irving, Ian; Blyth, Emily; Cheah, Chan; Cole, Theresa; Milliken, Sam; Yang, Hung; Greenwood, Matthew; Bardy, Peter; Kennedy, Glen; Larsen, Stephen; Conyers, Rachel; Hamad, Nada.
Afiliación
  • Perram J; Haematology Department, Westmead Hospital, Sydney, New South Wales, Australia.
  • Purtill D; Haematology department, Fiona Stanley Hospital, Western Australia, Perth, Australia.
  • Bajel A; Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Butler J; Haematology department, Royal Brisbane and Women's Hospital, Queensland, Brisbane, Australia.
  • O'Brien T; Haematology department, Sydney Children's Hospital, New South Wales, Sydney, Australia.
  • Teh B; Haematology department, National Centre for Infections in Cancer and Department of Infectious Diseases, Peter MacCallum Cancer Institute, Victoria, Melbourne, Australia.
  • Gilroy N; Haematology department, Centre for Infectious Diseases and Microbiology, Westmead Hospital, New South Wales, Sydney, Australia.
  • Ho PJ; Haematology department, Royal Prince Alfred Hospital and the University of Sydney, New South Wales, Sydney, Australia.
  • Doocey R; Haematology department, Auckland City Hospital, Auckland, New Zealand.
  • Hills T; Haematology department, Auckland City Hospital, Auckland, New Zealand.
  • Perera T; Haematology department, Wellington Blood and Cancer Centre, Wellington, New Zealand.
  • Douglas G; Haematology department, Austin Hospital, Victoria, Melbourne, Australia.
  • Ramachandran S; Department of Clinical Haematology, Oncology, Blood and Marrow Transplantation, Perth Children's Hospital, Perth, Western Australia, Australia.
  • Chee L; Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Trotman J; Haematology department, Concord Repatriation General Hospital and University of Sydney, New South Wales, Sydney, Australia.
  • Weinkove R; Haematology department, Wellington Blood and Cancer Centre and Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand.
  • Keogh S; Haematology department, University of Sydney and Westmead Hospital, New South Wales, Sydney, Australia.
  • Fraser C; Haematology department, Children's Health Queensland Hospital and Health Service, Queensland, Brisbane, Australia.
  • Cochrane T; Haematology department, Gold Coast University Hospital, Queensland, Gold Coast, Australia.
  • Watson AM; Haematology department, Liverpool Hospital, New South Wales, Sydney, Australia.
  • Diamond P; Leukaemia Foundation, Sydney, New South Wales, Australia.
  • Latimer M; Haematology department, Canberra Hospital, Australian Capital Territory, Canberra, Australia.
  • Irving I; ICON Cancer Centre, Brisbane, Queensland, Australia.
  • Blyth E; Haematology department, University of Sydney and Westmead Hospital, New South Wales, Sydney, Australia.
  • Cheah C; Haematology department, Sir Charles Gairdner Hospital, Western Australia, Perth, Australia.
  • Cole T; Haematology department, The Royal Children's Hospital Melbourne, Victoria, Melbourne, Australia.
  • Milliken S; Haematology department, St Vincent's Hospital Sydney and School of Clinical Medicine, Faculty of Medicine and Health, UNSW, New South Wales, Sydney, Australia.
  • Yang H; Australian Bone Marrow Donor Registry, Sydney, New South Wales, Australia.
  • Greenwood M; Haematology department, Royal North Shore Hospital, New South Wales, Sydney, Australia.
  • Bardy P; Haematology department, Royal Adelaide Hospital, South Australia, Adelaide, Australia.
  • Kennedy G; Haematology department, Royal Brisbane and Women's Hospital, Queensland, Brisbane, Australia.
  • Larsen S; Haematology department, Royal Prince Alfred Hospital and the University of Sydney, New South Wales, Sydney, Australia.
  • Conyers R; Haematology department, The Royal Children's Hospital Melbourne, Victoria, Melbourne, Australia.
  • Hamad N; Haematology department, St Vincent's Hospital Sydney and School of Clinical Medicine, Faculty of Medicine and Health, UNSW, New South Wales, Sydney, Australia.
Intern Med J ; 53(1): 119-125, 2023 01.
Article en En | MEDLINE | ID: mdl-36371767
Patients with post-haemopoietic stem cell transplant or chimeric antigen receptor T -cell (CAR-T) therapy face a significant risk of morbidity and mortality from coronavirus disease 2019 because of their immunosuppressed state. As case numbers in Australia and New Zealand continue to rise, guidance on management in this high-risk population is needed. Whilst we have learned much from international colleagues who faced high infection rates early in the pandemic, guidance relevant to local health system structures, medication availability and emerging therapies is essential to equip physicians to manage our patients optimally.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Receptores Quiméricos de Antígenos / COVID-19 Tipo de estudio: Guideline Límite: Humans País/Región como asunto: Oceania Idioma: En Revista: Intern Med J Asunto de la revista: MEDICINA INTERNA Año: 2023 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Australia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Receptores Quiméricos de Antígenos / COVID-19 Tipo de estudio: Guideline Límite: Humans País/Región como asunto: Oceania Idioma: En Revista: Intern Med J Asunto de la revista: MEDICINA INTERNA Año: 2023 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Australia